Digipath
Home > Boards > US Listed > Medical - Equipment >

Cytosorbents Corporation (CTSO)

CTSO RSS Feed 		Add CTSO Price Alert      Hide Sticky   Hide Intro
Moderator: orangecat, dah174174, caesare74
Search This Board: 
Last Post: 1/23/2019 4:34:29 PM - Followers: 210 - Board type: Free - Posts Today: 16

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 45 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter.

Digipath
CTSO
Current Price
Volume:
Bid Ask Day's Range
CTSO Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTSO News: Current Report Filing (8-k) 01/07/2019 05:13:02 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 12/11/2018 02:08:48 PM
CTSO News: Current Report Filing (8-k) 11/07/2018 05:20:24 PM
CTSO News: Quarterly Report (10-q) 11/06/2018 04:41:27 PM
CTSO News: Statement of Changes in Beneficial Ownership (4) 08/31/2018 03:36:45 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#14940   So your belief is that pretty much everyone hemopure36 01/23/19 04:34:29 PM
#14939   Doctors, nurses and patients AND company executives know ranchhand71 01/23/19 04:16:17 PM
#14938   over 400,000 shares traded on a down day. stingman49 01/23/19 03:35:48 PM
#14937   Fresenius; what data backs their sales? What Lakersrback 01/23/19 03:20:32 PM
#14936   Think what you want to. martys12 01/23/19 02:03:24 PM
#14935   Martys; my guess Fresnius is not responsible for slappie 01/23/19 02:01:33 PM
#14934   Hemopure, My understanding?????? Murph1953 01/23/19 01:13:57 PM
#14933   Not for sure I took it as what martys12 01/23/19 12:47:23 PM
#14932   What does “eligible to receive” mean? hemopure36 01/23/19 12:43:52 PM
#14931   Ranchhand71, for sure were testing $6.60 the 52 Burnttoast247 01/23/19 12:17:27 PM
#14930   Talked to my old classmate in Berlin a martys12 01/23/19 11:58:12 AM
#14929   Andy, DOCTORS ACCOLADES FOR USE OF CYTOSORB FILTER Burnttoast247 01/23/19 11:52:37 AM
#14927   CEO and CFO sold stock at $12? They ranchhand71 01/23/19 11:41:37 AM
#14926   WOW BERTHA, IMO,CRRT ABSOLUTELY NEEDS CYTOSOB FILTER INVOLVED Burnttoast247 01/23/19 11:14:43 AM
#14925   Case of the Week andy55q 01/23/19 07:20:24 AM
#14924   Same as stroke/TBI? "spinal cord injuries...damage occurs long Murph1953 01/22/19 11:28:41 PM
#14923   Thanks much Bertha for that link to BioMedCentral/Critical Care Murph1953 01/22/19 11:26:41 PM
#14922   https://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1665-6 berthabluefish1 01/22/19 09:26:24 PM
#14921   And we drop like a rock, right on Q. ml24 01/22/19 09:17:56 PM
#14920   Maybe CRRT needs Cytosorb to work better.https://www.ncbi.nlm.nih.gov/pubmed/302 berthabluefish1 01/22/19 09:16:05 PM
#14919   ANY COUNTRY THAT PAYS FOR HEALTHCARE... HadToHavit 01/22/19 06:30:33 PM
#14918   IMO, absolutely correct! caesare74 01/22/19 05:11:23 PM
#14917   Burnttoast: since Fresenius Medical is a well known caesare74 01/22/19 05:10:33 PM
#14916   These pre programmed sales & option buy sell Burnttoast247 01/22/19 05:02:24 PM
#14915   The only person in the last 6 months Bart31 01/22/19 04:55:00 PM
#14914   Caesare74 GOOD CALL Fresenius has huge footprint in Burnttoast247 01/22/19 04:54:55 PM
#14913   Bertha: it makes sense that China + Japan caesare74 01/22/19 04:30:39 PM
#14912   That’s either a blatant lie or blatant ignorance. hemopure36 01/22/19 04:01:04 PM
#14911   Officers keep selling shares too. Doesn't exude confidence slappie 01/22/19 03:29:14 PM
#14910   Amen to that Hadtosayit! Likely why we Lakersrback 01/22/19 02:23:17 PM
#14909   Folks… the "markets" are totally "jacked". Off HadToHavit 01/22/19 01:39:46 PM
#14908   EDTXF is partnered with Fresenius as well. Lakersrback 01/22/19 12:59:46 PM
#14907   I think when Chan exercised his expiring options fantomphan 01/22/19 12:09:26 PM
#14906   Is Cytosorbents Corporation’s CEO Pay Fair? from Simply biotech48 01/22/19 11:48:02 AM
#14905   Can see what market thinks about deal with slappie 01/22/19 11:44:56 AM
#14904   ANYONE, have info on time required fast track Burnttoast247 01/22/19 11:30:38 AM
#14903   Hey Lakersback your company has a PR today!! eskay1954 01/22/19 10:47:39 AM
#14902   REMEMBER The approval processes in each country very Burnttoast247 01/22/19 10:04:16 AM
#14901   Notice the part about CRRT treatment gradually increasing berthabluefish1 01/22/19 09:40:47 AM
#14900   Chan needs to concentrate on the technical/ operations greenaccountingbeen 01/22/19 09:15:54 AM
#14899   NEWS -- CytoSorbents Announces Expansion of CytoSorb® Partnership Paulness 01/22/19 09:12:13 AM
#14898   JGR The Fresenius agreement Mexico & South Korea Burnttoast247 01/22/19 09:12:07 AM
#14897   New partnership with Fresenius. I can't believe it. J G R 01/22/19 09:03:05 AM
#14896   News Today.Fresenius and Cytosorbents Expands Partnership to Korea berthabluefish1 01/22/19 08:44:28 AM
#14895   Why "and in cardiac surgery" as an after-thought Lakersrback 01/22/19 08:40:22 AM
#14894   Andy, are there any case studies with Cytosorb Burnttoast247 01/22/19 08:35:49 AM
#14893   Bertha, agree so copied 3rd paragraph for others: Burnttoast247 01/22/19 08:29:17 AM
#14892   Stingman, Not sure if average but IMO certainly Burnttoast247 01/22/19 08:13:32 AM
#14891   Also, Burnt, if you like that news letter, Murph1953 01/21/19 09:18:34 PM
#14890   Burnt, I subscribe to that newsletter too. Murph1953 01/21/19 08:53:47 PM
PostSubject
© 2019 InvestorsHub.com, Inc.